The Two Faces of NF-κB Signaling in Cancer Development and Therapy

Cancer Cell

Volumn 20, Issue 5, 2011, Pages 556-558

  Klein, Ulf ^a,b   Ghosh, Sankar ^b  

^a New York Presbyterian Morgan Stanley Children's Hospital   (United States)

^b Howard Hughes Medical Institute   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

IMMUNOGLOBULIN ENHANCER BINDING PROTEIN; PROTEIN BCL 2; TRANSCRIPTION FACTOR RELA;

B CELL LYMPHOMA; CANCER CHEMOTHERAPY; CANCER INHIBITION; CARCINOGENESIS; GENE MUTATION; HUMAN; LARGE CELL LYMPHOMA; NONHODGKIN LYMPHOMA; ONCOGENE MYC; PRIORITY JOURNAL; PROTEIN FUNCTION; SENESCENCE; SHORT SURVEY; SIGNAL TRANSDUCTION;

EID: 81255192180     PISSN: 15356108     EISSN: 18783686     Source Type: Journal    
DOI: 10.1016/j.ccr.2011.10.026     Document Type: Short Survey

References (10)

1. Ben-Neriah Y., Karin M. Nat. Immunol. 2011, 12:715-723.
2. Chien Y., Scuoppo C., Wang X., Fang X., Balgley B., Bolden J.E., Premsrirut P., Luo W., Chicas A., Lee C.S., et al. Genes Dev. 2011, 25:2125-2136.
3. Coppé J.P., Patil C.K., Rodier F., Sun Y., Muñoz D.P., Goldstein J., Nelson P.S., Desprez P.Y., Campisi J. PLoS Biol. 2008, 6:2853-2868.
4. Hayden M.S., Ghosh S. Cell 2008, 132:344-362.
5. Jing H., Kase J., Dörr J.R., Milanovic M., Lenze D., Grau M., Beuster G., Ji S., Reimann M., Lenz P., et al. Genes Dev. 2011, 25:2137-2146.
6. Kuilman T., Peeper D.S. Nat. Rev. Cancer 2009, 9:81-94.
7. Kuilman T., Michaloglou C., Mooi W.J., Peeper D.S. Genes Dev. 2010, 24:2463-2479.
8. Rui L., Schmitz R., Ceribelli M., Staudt L.M. Nat. Immunol. 2011, 12:933-940.
9. Schmitt C.A., Fridman J.S., Yang M., Lee S., Baranov E., Hoffman R.M., Lowe S.W. Cell 2002, 109:335-346.
10. Staudt L.M. Cold Spring Harb. Perspect. Biol. 2010, 2:a000109.